ACQUISITIONS - Net Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands |
Sep. 30, 2024 |
Apr. 30, 2024 |
Dec. 31, 2023 |
---|---|---|---|
Assets acquired | |||
Deferred tax asset | $ 185,016 | $ 144,162 | |
TOTAL ASSETS | 928,135 | 811,448 | |
Total liabilities assumed | $ 331,331 | $ 344,456 | |
Epygenix Acquisition | |||
Assets acquired | |||
Acquired in-process research and development | $ 17,095 | ||
Deferred tax asset | 18,268 | ||
Other assets | 590 | ||
TOTAL ASSETS | 35,953 | ||
Total liabilities assumed | 2,817 | ||
Net assets acquired | $ 33,136 |
X | ||||||||||
- Definition Sum of the carrying amounts of acquired in-process research and development. No definition available.
|
X | ||||||||||
- Definition Amount of asset recognized for present right to economic benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of net assets (liabilities). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Details
|